+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Use of new methods for detection of beta-lactamases with extended-spectrum substrates (ESBLs)



Use of new methods for detection of beta-lactamases with extended-spectrum substrates (ESBLs)



Medycyna Doswiadczalna i Mikrobiologia 54(3): 225-231



The aim of performed examinations was to compare results of two methods applied for the detection of extended-spectrum beta-lactamases (ESBLs). Two hundred and sixty strains of Gram-negative rods were cultured from clinical specimens obtained from hospitalized patients. These strains were identified as ESBL-positive on the basis of the double-disc method (DDST) according to Jarlier et al. (1988) results. Identification of strains was performed in automatic ATB Expression system (bioMerieux, France). All strains were determined using a novel test for detection of ESBL-type enzymes (DD) according to Appleton (1999). Two discs are applied in this test: with cefpodoxime (CPD) and with cefpodoxime/clavulanate (CD 01, diagnostic disc). Consistent results of two methods (DDST and DD) were obtained in the case of 166 from among 260 of examined strains (60.4%). Consistent results concerned 161 out of 222 examined strains of enteric rods (72.5%) and only 5 from among 38 of other strains (mostly belonging to the group of non-fermenting rods). On the basis of performed investigations it can be stated that the novel method of extended-spectrum beta-lactamases (ESBLs) detection (DD) according to Appleton (1999) is more objective and easier for interpretation than the double-disc synergy test (DDST) according to Jarlier et al. (DDST), which is widely applied in the routine microbiological diagnostics.

(PDF emailed within 1 workday: $29.90)

Accession: 050910729

Download citation: RISBibTeXText

PMID: 12632657


Related references

Extended-spectrum beta-lactamases (ESbLs): characterization, epidemiology and detection. Critical Reviews in Microbiology 30(1): 25-32, 2004

Laboratory detection of extended-spectrum beta-lactamases (ESBLs)--the need for a reliable, reproducible method. Diagnostic Microbiology and Infectious Disease 37(4): 293-295, 2000

qnr Prevalence in Extended Spectrum Beta-lactamases (ESBLs) and None-ESBLs Producing Escherichia coli Isolated from Urinary Tract Infections in Central of Iran. Iranian Journal of Basic Medical Sciences 14(5): 458-464, 2011

Substrate specificity of HMRZ-86 for beta-lactamases, including extended-spectrum beta-lactamases (ESBLs). Journal of Infection and ChemoTherapy 13(6): 390-395, 2007

Detection of CTX-M-15, CTX-M-22, and SHV-2 extended-spectrum beta-lactamases (ESBLs) in Escherichia coli fecal-sample isolates from pig farms in China. Foodborne Pathogens and Disease 6(3): 297-304, 2009

Evaluation of the VITEK 2 AST-N111 card for detection of extended-spectrum beta-lactamases (ESBLs) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca compared to ESBL Etests and combination disk methods. European Journal of Clinical Microbiology & Infectious Diseases 30(7): 869-872, 2011

Extended-spectrum beta-lactamases (ESBLs) producing bacteria. Nihon Rinsho. Japanese Journal of Clinical Medicine 59(4): 694-700, 2001

Performance of methods for detection of extended-spectrum beta-lactamases applied to clinical enterobacterial strains producing IBC-type beta-lactamases. Journal of Clinical Microbiology 41(2): 912-912, 2003

Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. Journal of Antimicrobial ChemoTherapy 56(1): 52-59, 2005

Positive extended-spectrum-beta-lactamase (ESBL) screening results may be due to AmpC beta-lactamases more often than to ESBLs. Journal of Clinical Microbiology 48(2): 673-674, 2010

Two different extended-spectrum beta-lactamases (ESBLs) in one of the first ESBL-producing salmonella isolates in Poland. Journal of Clinical Microbiology 40(3): 1095-1097, 2002

Evolution and epidemiology of extended-spectrum beta-lactamases (ESBLs) and ESBL-producing microorganisms. Clinical Microbiology and Infection 7(11): 597-608, 2001

Detection of novel nucleotide substitutions resulting amino acid substitutions in TEM type beta-lactamase gene isolated from a clinically isolated extended spectrum beta-lactamases (ESBLs) productive Escherichia coli. Rinsho Byori. Japanese Journal of Clinical Pathology 51(3): 201-207, 2003